GU Cancers 2020 | Nivolumab for nccRCC

Laurence Albiges

Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France discusses the methods and results of the ACSe study (NCT03012581), which investigated the use of nivolumab in rare cancers such as metastatic non-clear cell renal cell carcinoma (nccRCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter